APA
Hodi F. S., Corless C. L., Giobbie-Hurder A., Fletcher J. A., Zhu M., Marino-Enriquez A., Friedlander P., Gonzalez R., Weber J. S., Gajewski T. F., O'Day S. J., Kim K. B., Lawrence D., Flaherty K. T., Luke J. J., Collichio F. A., Ernstoff M. S., Heinrich M. C., Beadling C., Zukotynski K. A., Yap J. T., Van den Abbeele A. D., Demetri G. D. & Fisher D. E. (20131122). Imatinib for melanomas harboring mutationally activated or amplified KIT arising on mucosal, acral, and chronically sun-damaged skin. : Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
Chicago
Hodi F Stephen, Corless Christopher L, Giobbie-Hurder Anita, Fletcher Jonathan A, Zhu Meijun, Marino-Enriquez Adrian, Friedlander Philip, Gonzalez Rene, Weber Jeffrey S, Gajewski Thomas F, O'Day Steven J, Kim Kevin B, Lawrence Donald, Flaherty Keith T, Luke Jason J, Collichio Frances A, Ernstoff Marc S, Heinrich Michael C, Beadling Carol, Zukotynski Katherine A, Yap Jeffrey T, Van den Abbeele Annick D, Demetri George D and Fisher David E. 20131122. Imatinib for melanomas harboring mutationally activated or amplified KIT arising on mucosal, acral, and chronically sun-damaged skin. : Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
Harvard
Hodi F. S., Corless C. L., Giobbie-Hurder A., Fletcher J. A., Zhu M., Marino-Enriquez A., Friedlander P., Gonzalez R., Weber J. S., Gajewski T. F., O'Day S. J., Kim K. B., Lawrence D., Flaherty K. T., Luke J. J., Collichio F. A., Ernstoff M. S., Heinrich M. C., Beadling C., Zukotynski K. A., Yap J. T., Van den Abbeele A. D., Demetri G. D. and Fisher D. E. (20131122). Imatinib for melanomas harboring mutationally activated or amplified KIT arising on mucosal, acral, and chronically sun-damaged skin. : Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
MLA
Hodi F Stephen, Corless Christopher L, Giobbie-Hurder Anita, Fletcher Jonathan A, Zhu Meijun, Marino-Enriquez Adrian, Friedlander Philip, Gonzalez Rene, Weber Jeffrey S, Gajewski Thomas F, O'Day Steven J, Kim Kevin B, Lawrence Donald, Flaherty Keith T, Luke Jason J, Collichio Frances A, Ernstoff Marc S, Heinrich Michael C, Beadling Carol, Zukotynski Katherine A, Yap Jeffrey T, Van den Abbeele Annick D, Demetri George D and Fisher David E. Imatinib for melanomas harboring mutationally activated or amplified KIT arising on mucosal, acral, and chronically sun-damaged skin. : Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 20131122.